GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » EV-to-Revenue

Nuvation Bio (Nuvation Bio) EV-to-Revenue : (As of Apr. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nuvation Bio's enterprise value is $1,107.14 Mil. Nuvation Bio's Revenue for the trailing twelve months (TTM) ended in Sep. 2021 was $0.00 Mil. Therefore, Nuvation Bio's EV-to-Revenue for today is .

The historical rank and industry rank for Nuvation Bio's EV-to-Revenue or its related term are showing as below:

NUVB's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.66
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-27), Nuvation Bio's stock price is $5.435. Nuvation Bio's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 was $0.00. Therefore, Nuvation Bio's PS Ratio for today is .

Nuvation Bio EV-to-Revenue Historical Data

The historical data trend for Nuvation Bio's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio EV-to-Revenue Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
EV-to-Revenue
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
EV-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Nuvation Bio's EV-to-Revenue

For the Biotechnology subindustry, Nuvation Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nuvation Bio's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's EV-to-Revenue falls into.


Nuvation Bio EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nuvation Bio's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1107.142/0
=

Nuvation Bio's current Enterprise Value is $1,107.14 Mil.
Nuvation Bio's Revenue for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio  (NYSE:NUVB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nuvation Bio's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=5.435/0
=

Nuvation Bio's share price for today is $5.435.
Nuvation Bio's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » EV-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Website
https://www.nuvationbio.com
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.